Background: Caspases are a family of cysteine proteases that have important
intracellular roles in inflammation and apoptosis. Caspase-8 activates dow
nstream caspases which are unable to carry out autocatalytic processing and
activation. Caspase-8 is designated as an initiator caspase and is believe
d to sit at the apex of the Fas- or TNF-mediated apoptotic cascade, In view
of this role, the enzyme is an attractive target for the design of inhibit
ors aimed at blocking the undesirable cell death associated with a range of
degenerative disorders.
Results: The structure of recombinant human caspase-8, covalently modified
with the inhibitor acetyl-Ile-Glu-Thr-Asp-aldehyde, has been determined by
X-ray crystallography to 1.2 Angstrom resolution. The asymmetric unit conta
ins the p18-p11 heterodimer; the biologically important molecule contains t
wo dimers. The overall fold is very similar to that of caspase-1 and caspas
e-3, but significant differences exist in the substrate-binding region, The
structure answers questions about the enzyme-inhibitor complex that could
not be explained from earlier caspase structures solved at lower resolution
,
Conclusions: The catalytic triad in caspase-8 comprises Cys360, His317 and
the backbone carbonyl oxygen atom of Arg258, which points towards the NE at
om of His317. The oxygen atom attached to the tetrahedral carbon in the thi
ohemiacetal group of the inhibitor is hydrogen bonded to N delta of His317,
and is not in a region characteristic of a classical 'oxyanion hole'. The
N-acetyl group of the inhibitor is in the trans configuration. The caspase-
8-inhibitor structure provides the basis for understanding structure/functi
on relationships in this important initiator of the proteolytic cascade tha
t leads to programmed cell death.